Cite Filings / ALLO
Feed Companies Filings Check
Sign in

CIK 0001737287

  • Non-accelerated filer
  • Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
823562771
Phone
+1 650-457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Filings Financials Insiders Search text
All 588 Financials 121 Shareholder Meetings 10 Executive Compensation 104 Insider Trading 275 Beneficial Ownership Interest 78 Business Combinations 90 Public Offerings 28 Mutual Funds and ETFs 8 Others 81
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2018-10-02
  3. S-1/A Offering Registration Statement 2018-10-02
  4. UPLOAD Other SEC-generated Letter 2018-09-26
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2018-09-26
  6. S-1/A Offering Registration Statement 2018-09-17
  7. CORRESP Other Correspondence Between Filers and SEC Staff 2018-09-14
  8. S-1 Offering Registration Statement 2018-09-14
  9. UPLOAD Other SEC-generated Letter 2018-09-11

Page 2 of 2 · 28 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…